A growing number of articles present increased LH expression as a prognostic marker associated with poor prognosis in patients with osteosarcoma [68], glioblastoma [27], oral squamous cell carcinoma [25,69], and other cancer diseases. This evidence concerns the gene PLOD1 and cancer.